18 related articles for article (PubMed ID: 16945012)
1. Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species.
Moon HJ; Kim SE; Yun YP; Hwang YS; Bang JB; Park JH; Kwon IK
Exp Mol Med; 2011 Nov; 43(11):605-12. PubMed ID: 21832867
[TBL] [Abstract][Full Text] [Related]
2. Exploring codon optimization and response surface methodology to express biologically active transmembrane RANKL in E. coli.
Maharjan S; Singh B; Bok JD; Kim JI; Jiang T; Cho CS; Kang SK; Choi YJ
PLoS One; 2014; 9(5):e96259. PubMed ID: 24809485
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory Effect of KP-A038 on Osteoclastogenesis and Inflammatory Bone Loss Is Associated With Downregulation of Blimp1.
Ihn HJ; Lee T; Lee D; Bae JS; Kim SH; Jang IH; Bae YC; Shin HI; Park EK
Front Pharmacol; 2019; 10():367. PubMed ID: 31024321
[TBL] [Abstract][Full Text] [Related]
4. Predicting cytotoxicity from heterogeneous data sources with Bayesian learning.
Langdon SR; Mulgrew J; Paolini GV; van Hoorn WP
J Cheminform; 2010 Dec; 2(1):11. PubMed ID: 21143909
[TBL] [Abstract][Full Text] [Related]
5. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
Shim KS; Ma CJ; Kim DS; Ma JY
J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017
[TBL] [Abstract][Full Text] [Related]
6. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
Yoon WJ; Kim KN; Heo SJ; Han SC; Kim J; Ko YJ; Kang HK; Yoo ES
Biochem Biophys Res Commun; 2013 May; 434(4):892-7. PubMed ID: 23611776
[TBL] [Abstract][Full Text] [Related]
7. Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss.
Guan H; Zhao L; Cao H; Chen A; Xiao J
FASEB J; 2015 Mar; 29(3):1092-101. PubMed ID: 25466887
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of andrographolide in RAW 264.7 murine macrophage osteoclastogenesis by downregulating the nuclear factor-kappaB signaling pathway.
Ren YQ; Zhou YB
Genet Mol Res; 2015 Dec; 14(4):15955-61. PubMed ID: 26662387
[TBL] [Abstract][Full Text] [Related]
9. Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
Ko SY
Arch Oral Biol; 2012 Dec; 57(12):1623-32. PubMed ID: 22795564
[TBL] [Abstract][Full Text] [Related]
10. High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitor.
Chen T; Knapp AC; Wu Y; Huang J; Lynch JS; Dickson JK; Lawrence RM; Feyen JH; Agler ML
Assay Drug Dev Technol; 2006 Aug; 4(4):387-96. PubMed ID: 16945012
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
